Yan, R.; Huang, X.; Liu, H.; Xiao, Z.; Liu, J.; An, G.; Ge, Y.
DCLK1 Drives EGFR-TKI-Acquired Resistance in Lung Adenocarcinoma by Remodeling the Epithelial–Mesenchymal Transition Status. Biomedicines 2023, 11, 1490.
https://doi.org/10.3390/biomedicines11051490
AMA Style
Yan R, Huang X, Liu H, Xiao Z, Liu J, An G, Ge Y.
DCLK1 Drives EGFR-TKI-Acquired Resistance in Lung Adenocarcinoma by Remodeling the Epithelial–Mesenchymal Transition Status. Biomedicines. 2023; 11(5):1490.
https://doi.org/10.3390/biomedicines11051490
Chicago/Turabian Style
Yan, Rui, Xuying Huang, Heshu Liu, Zeru Xiao, Jian Liu, Guangyu An, and Yang Ge.
2023. "DCLK1 Drives EGFR-TKI-Acquired Resistance in Lung Adenocarcinoma by Remodeling the Epithelial–Mesenchymal Transition Status" Biomedicines 11, no. 5: 1490.
https://doi.org/10.3390/biomedicines11051490
APA Style
Yan, R., Huang, X., Liu, H., Xiao, Z., Liu, J., An, G., & Ge, Y.
(2023). DCLK1 Drives EGFR-TKI-Acquired Resistance in Lung Adenocarcinoma by Remodeling the Epithelial–Mesenchymal Transition Status. Biomedicines, 11(5), 1490.
https://doi.org/10.3390/biomedicines11051490